drugset
drugset / Trial / NCT05339633

Study in Healthy Adult Female Subjects

NCT05339633 ↗

Phase 1 Completed 8 enrolled InventisBio Co., Ltd
NaSingle-groupOpen-labelOther

Summary

An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of \[14C\] D-0502 Following Single Oral Dose Administration

Timeline

Start
2022-03-29
Primary completion
2022-08-02
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject TARAGARESTRANT Small molecule — Oral

Indications

No indication recorded.